Aidoc is bringing a system that can interpret images and make draft reports for radiologists to the FDA as the medtech ...

Abbott will market Freenome’s SimpleScreen CRC test in the U.S., alongside its Cologuard stool test. SimpleScreen will ...

The device, bought during Boston Scientific’s acquisition of Silk Road Medical, has a risk of catheter tip separation during ...

Tempus AI’s planned acquisition follows recent interest in blood-based cancer tests across the medtech industry.

Multiple factors could get in the way of confirming a new commissioner before the midterm elections, experts said, leaving ...

The Exact Sciences acquisition, which closed in March, fueled more than 40% growth in Abbott’s diagnostics sales in the ...

The deal is the latest in a series of pacts that GE HealthCare has made with health systems, including with Sutter Health and ...

Shareholders approved a plan to dissolve the robot developer, at one time a well-financed contender to challenge surgical ...

The computing platform will make its debut at the Society of Robotic Surgery meeting this week, as Medtronic challenges ...

Bhatt is also chair of the Food and Drug Administration’s first digital health advisory committee, which provides physician ...

The cyberattack follows Abbott’s recent $21 billion purchase of Exact Sciences. Abbott did not disclose what kind of ...

DePuy expects the technology, which doesn’t use screws, will strengthen its spine business and integrate into its Velys ...